Elke Valk
Solarzentrum Stuttgart (Germany)(DE)
Publications by Year
Research Areas
CNS Lymphoma Diagnosis and Treatment, Glioma Diagnosis and Treatment, Lymphoma Diagnosis and Treatment, Health Systems, Economic Evaluations, Quality of Life, Cardiovascular Function and Risk Factors
Most-Cited Works
- → High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial(2016)169 cited
- → High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group(2017)91 cited
- → High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix)(2016)69 cited
- → Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)(2022)43 cited
- → Recognition and quantification of myocardial injury by means of plasma enzyme and isoenzyme activities after cardiac surgery.(1979)29 cited
- → Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma(2022)11 cited
- → Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial(2023)9 cited
- → Quality of Life in Patients with Primary CNS Lymphoma - a Pooled Analysis from Three Prospective Multicentre Trials(2016)2 cited
- → Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma(2025)2 cited
- → Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first- line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial(2023)1 cited